Yttrium Y 90 Ibritumomab Tiuxetan, Fludarabine, Radiation Therapy, and Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Conditions
- B-cell Chronic Lymphocytic Leukemia
- Nodal Marginal Zone B-cell Lymphoma
- Recurrent Adult Burkitt Lymphoma
- Recurrent Adult Diffuse Large Cell Lymphoma
- Recurrent Adult Diffuse Mixed Cell Lymphoma
- Recurrent Adult Diffuse Small Cleaved Cell Lymphoma
- Recurrent Adult Grade III Lymphomatoid Granulomatosis
- Recurrent Adult Immunoblastic Large Cell Lymphoma
- Recurrent Adult Lymphoblastic Lymphoma
- Recurrent Grade 1 Follicular Lymphoma
- Recurrent Grade 2 Follicular Lymphoma
- Recurrent Grade 3 Follicular Lymphoma
- Recurrent Mantle Cell Lymphoma
- Recurrent Marginal Zone Lymphoma
- Recurrent Small Lymphocytic Lymphoma
- Splenic Marginal Zone Lymphoma
- Waldenström Macroglobulinemia
Interventions
- BIOLOGICAL: rituximab
- DRUG: cyclosporine
- DRUG: fludarabine phosphate
- DRUG: mycophenolate mofetil
- RADIATION: yttrium Y 90 ibritumomab tiuxetan
- PROCEDURE: peripheral blood stem cell transplantation
- PROCEDURE: allogeneic hematopoietic stem cell transplantation
- RADIATION: total-body irradiation
Sponsor
Fred Hutchinson Cancer Center
Collaborators